References
- Kerkar SP, Restifo NP. Cellular constituents of immune escape within the tumor microenvironment. Cancer Res 2012;72:3125-3130.
- Striz I, Brabcova E, Kolesar L, et al. Cytokine networking of innate immunity cells: a potential target of therapy. Clin Sci (Lond) 2014;126:593-612.
- Legitimo A, Consolini R, Failli A, et al. Dendritic cell defects in the colorectal cancer. Hum Vaccin Immunother 2014;10:3224-3235.
- Gulubova MV, Ananiev JR, Vlaykova TI, et al. Role of dendritic cells in progression and clinical outcome of colon cancer. Int J Colorectal Dis 2012;27:159-169.
- Orsini G, Legitimo A, Failli A, et al. Quantification of blood dendritic cells in colorectal cancer patients during the course of disease. Pathol Oncol Res 2014;20:267-276.
- Morse MA, Niedzwiecki D, Marshall JL, et al. A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer. Ann Surg 2013;258:879-886.
- Mantovani A, Marchesi F, Malesci A, et al. Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol 2017;14:399-416.
- Bogels M, Braster R, Nijland PG, et al. Carcinoma origin dictates differential skewing of monocyte function. Oncoimmunology 2012;1:798-809.
- Roslyn Kemp SN, Edward Taylor, Elliott Dunn, Fran Munro, Michael Black and John McCall. Colorectal tumoru associated macrophages are more pro-inflammatory than adjacent control bowel tissue macrophage populations (TUM6P.1003). J Immunol 2015;194(1 Supplement):1.
- Cavnar MJ, Turcotte S, Katz SC, et al. Tumor-Associated Macrophage Infiltration in Colorectal Cancer Liver Metastases is Associated With Better Outcome. Ann Surg Oncol 2017;24:1835-1842.
- Najjar YG, Finke JH. Clinical perspectives on targeting of myeloid derived suppressor cells in the treatment of cancer. Front Oncol 2013;3:49.
- Inamoto S, Itatani Y, Yamamoto T, et al. Loss of SMAD4 Promotes Colorectal Cancer Progression by Accumulation of Myeloid-Derived Suppressor Cells through the CCL15-CCR1 Chemokine Axis. Clin Cancer Res 2016;22:492-501.
- Qin H, Lerman B, Sakamaki I, et al. Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice. Nat Med 2014;20:676-681.
- Morvan MG, Lanier LL. NK cells and cancer: you can teach innate cells new tricks. Nat Rev Cancer 2016;16:7-19.
- Jobin G, Rodriguez-Suarez R, Betito K. Association Between Natural Killer Cell Activity and Colorectal Cancer in High-Risk Subjects Undergoing Colonoscopy. Gastroenterology 2017;153:980-987.